CYCLERION THERAPEUTICS, INC. Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense
CYCLERION THERAPEUTICS, INC. (CYCN) reported Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense of $100.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense · last filed 2021-02-25
- CYCLERION THERAPEUTICS, INC. deferred compensation arrangement with individual, allocated share-based compensation expense for fiscal 2020 was $100.00K, a 0.00% change from fiscal 2019.
- CYCLERION THERAPEUTICS, INC. deferred compensation arrangement with individual, allocated share-based compensation expense for fiscal 2019 was $100.00K.
| Period end | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense 12 month |
|---|---|
| 2020-12-31 | $100.00K 10-K · filed 2021-02-25 |
| 2019-12-31 | $100.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |